Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

895 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
"Hyperglycosylated hCG in the management of quiescent and chemorefractory gestational trophoblastic diseases".
Seckl MJ, Savage PM, Hancock BW, Berkowitz RS, Goldstein DP, Lurain JR, Schink JC, Cagayan FM, Golfier F, Ngan H, Wake N, Osborne R, Sasaki S, Charry RC, Wong LC, Sekharan PK, Djamhoer MA, Massuger L, Belfort P, Kim SJ, Lee C, Jung SG. Seckl MJ, et al. Among authors: osborne r. Gynecol Oncol. 2010 Jun;117(3):505-6; author reply 506-7. doi: 10.1016/j.ygyno.2010.01.016. Epub 2010 Feb 23. Gynecol Oncol. 2010. PMID: 20181383 No abstract available.
First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
Alazzam M, Tidy J, Hancock BW, Osborne R, Lawrie TA. Alazzam M, et al. Among authors: osborne r. Cochrane Database Syst Rev. 2012 Jul 11;7(7):CD007102. doi: 10.1002/14651858.CD007102.pub3. Cochrane Database Syst Rev. 2012. PMID: 22786502 Free PMC article. Updated. Review.
Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.
Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA. Alazzam M, et al. Among authors: osborne r. Cochrane Database Syst Rev. 2016 Jan 13;2016(1):CD008891. doi: 10.1002/14651858.CD008891.pub3. Cochrane Database Syst Rev. 2016. PMID: 26760424 Free PMC article. Review.
First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
Lawrie TA, Alazzam M, Tidy J, Hancock BW, Osborne R. Lawrie TA, et al. Among authors: osborne r. Cochrane Database Syst Rev. 2016 Jun 9;2016(6):CD007102. doi: 10.1002/14651858.CD007102.pub4. Cochrane Database Syst Rev. 2016. PMID: 27281496 Free PMC article. Review.
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate.
Dekeister K, Bolze PA, Tod M, Tod R, Massardier J, Lotz JP, Hajri T, Colomban O, Seckl MJ, Osborne R, Freyer G, Golfier F, You B. Dekeister K, et al. Among authors: osborne r. Cancer Chemother Pharmacol. 2020 Jul;86(1):15-24. doi: 10.1007/s00280-020-04086-0. Epub 2020 Jun 4. Cancer Chemother Pharmacol. 2020. PMID: 32500221
High-dose methotrexate for gestational trophoblastic disease.
Elit L, Covens A, Osborne R, Gerulath A, Murphy J, Rosen B, Sturgeon J. Elit L, et al. Among authors: osborne r. Gynecol Oncol. 1994 Sep;54(3):282-7. doi: 10.1006/gyno.1994.1211. Gynecol Oncol. 1994. PMID: 7522198 Clinical Trial.
895 results